Physician profile

Paulo Guillinta

Cardiovascular Disease · Chula Vista, CA

NPI 1881661536

$29,151.66

in general payments reported to CMS, 2019-2025

20 companies · $1,318 in 2025

The $1,318 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$8,625.00
Food and Beverage$4,756.16
Travel and Lodging$3,088.29

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $23,947.48 2019-2025 Amplatzer Talisman, Mitraclip, Triclip
Edwards Lifesciences Corporation $1,326.90 2023-2025 Sapien 3 Ultra Resilia, Evoque, Pascal
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $525.01 2020-2024 Lifevest
Siemens Medical Solutions USA, INC. $489.99 2024-2025 Acuson Origin Diagnostic Ultrasound System
Medtronic Vascular, INC. $487.45 2019-2020
Philips North America LLC $472.67 2023-2024 (5044) Mcot, (Ck4) Mcot
Medtronic, INC. $422.82 2021-2023 Corevalve Evolut R
Abiomed $262.83 2019-2025
Astrazeneca Pharmaceuticals LP $258.69 2019-2020
Amgen INC. $175.55 2019-2024
Shockwave Medical, INC $152.00 2025
E.R. Squibb & Sons, L.L.C. $138.02 2024 Camzyos
Cvrx, INC. $129.50 2021
Boehringer Ingelheim Pharmaceuticals, INC. $117.47 2020
Boston Scientific Corporation $93.57 2023 Watchman
Show all 19 companies
CompanyGeneral paymentsYearsTop products
Getinge USA Sales, LLC $81.80 2023-2024 Cardiohelp
Bard Peripheral Vascular, INC. $38.55 2025 Lutonix Drug Coated Balloon
Pfizer INC. $18.18 2019
Lantheus Medical Imaging, INC. $13.18 2019

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Paulo Guillinta

$29,151.66

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $1,318 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/357688/paulo-guillinta

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.